Center for Inflammatory Bowel Disease Metrics
|
Dr. Navaneethan |
161 |
|
Dr. Agarwal |
146 |
|
Ryan Anderson, PA-C |
90 |
|
Smithamol- Greegorious |
69 |
|
Dietitian |
57 |
|
Mental Health Therapist |
40 |
|
Total Visits |
563 |
|
Colonoscopy |
189 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, ERCP, Ileoscopy, Flex Sigmoidoscopy |
56 |
|
|
Total Procedures |
245 |
|
New IBD Consult Referral |
162 |
|
Referrals to Surgery from IBD clinic |
10 |
|
Hospital Admissions of patients cared in IBD clinic |
2 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial — Guselkumab in UC |
|
|
AMAM — Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA — Erasmo in CD |
|
|
Dr. Navaneethan |
67 |
|
Dr. Agarwal |
180 |
|
Ryan Anderson, PA-C |
111 |
|
Smithamol- Greegorious |
72 |
|
Dietitian |
63 |
|
Mental Health Therapist |
33 |
|
Total Visits |
526 |
|
Colonoscopy |
97 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ileoscopy, Flexible Sigmoidoscopy |
33 |
|
|
Total Procedures |
130 |
|
New IBD Consult Referral |
169 |
|
Referrals to Surgery from IBD clinic |
9 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial — Guselkumab in UC |
|
|
AMAM — Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA — Erasmo in CD |
|
|
Dr. Navaneethan |
207 |
|
Dr. Agarwal |
203 |
|
Ryan Anderson, PA-C |
77 |
|
Smithamol- Greegorious |
68 |
|
Dietitian |
79 |
|
Mental Health Therapist |
14 |
|
Total Visits |
618 |
|
Colonoscopy |
193 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ileoscopy, Flexible Sigmoidoscopy |
62 |
|
|
Total Procedures |
255 |
|
New IBD Consult Referral |
134 |
|
Referrals to Surgery from IBD clinic |
20 |
|
Hospital Admissions of patients cared in IBD clinic |
2 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial — Guselkumab in UC |
|
|
AMAM — Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA — Erasmo in CD |
|
|
Dr. Navaneethan |
191 |
|
Dr. Agarwal |
164 |
|
Ryan Anderson, PA-C |
65 |
|
Smithamol- Greegorious |
90 |
|
Dietitian |
82 |
|
Mental Health Therapist |
- |
|
Total Visits |
592 |
|
Colonoscopy |
193 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ileoscopy, Flexible Sigmoidoscopy |
62 |
|
|
Total Procedures |
255 |
|
New IBD Consult Referral |
144 |
|
Referrals to Surgery from IBD clinic |
13 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial — Guselkumab in UC |
|
|
AMAM — Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA — Erasmo in CD |
|
|
Dr. Navaneethan |
140 |
|
Dr. Agarwal |
193 |
|
Ryan Anderson, PA-C |
98 |
|
Smithamol- Greegorious |
66 |
|
Dietitian |
83 |
|
Mental Health Therapist |
- |
|
Total Visits |
580 |
|
Colonoscopy |
166 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ileoscopy, Flexible Sigmoidoscopy |
54 |
|
|
Total Procedures |
220 |
|
New IBD Consult Referral |
129 |
|
Referrals to Surgery from IBD clinic |
11 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial — Guselkumab in UC |
|
|
AMAM — Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA — Erasmo in CD |
|
|
Dr. Navaneethan |
178 |
|
Dr. Agarwal |
98 |
|
Ryan Anderson, PA-C |
87 |
|
Smithamol- Greegorious |
60 |
|
Dietitian |
80 |
|
Mental Health Therapist |
40 |
|
Total Visits |
543 |
|
Colonoscopy |
175 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ileoscopy, Flexible Sigmoidoscopy |
31 |
|
|
Total Procedures |
206 |
|
New IBD Consult Referral |
126 |
|
Referrals to Surgery from IBD clinic |
13 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial — Guselkumab in UC |
|
|
AMAM — Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA — Erasmo in CD |
|
|
Dr. Navaneethan |
177 |
|
Dr. Agarwal |
127 |
|
Ryan Anderson, PA-C |
50 |
|
Smithamol- Greegorious |
57 |
|
Dietitian |
79 |
|
Mental Health Therapist |
43 |
|
Total Visits |
533 |
|
Colonoscopy |
194 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ileoscopy, Flexible Sigmoidoscopy |
51 |
|
|
Total Procedures |
245 |
|
New IBD Consult Referral |
154 |
|
Referrals to Surgery from IBD clinic |
7 |
|
Hospital Admissions of patients cared in IBD clinic |
2 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
QUASAR trial — Guselkumab in UC |
|
|
AMAM — Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA — Erasmo in CD |
|
|
Dr. Navaneethan |
170 |
|
Dr. Agarwal |
101 |
|
Ryan Anderson, PA-C |
80 |
|
Smithamol- Greegorious |
55 |
|
Dietician |
69 |
|
Mental Health Therapist |
58 |
|
Total Visits |
533 |
|
Colonoscopy |
114 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ilescopy, Flexible Sigmoidoscopy |
22 |
|
|
Total Procedures |
136 |
|
New IBD Consult Referral |
131 |
|
Referrals to Surgery from IBD clinic |
0 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA-Erasmo in CD |
|
|
Dr. Navaneethan |
191 |
|
Dr. Agarwal |
12 |
|
Ryan Anderson, PA-C |
87 |
|
Smithamol- Greegorious |
57 |
|
Dietician |
85 |
|
Mental Health Therapist |
52 |
|
Total Visits |
484 |
|
Colonoscopy |
114 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ilescopy, Flexible Sigmoidoscopy |
33 |
|
|
Total Procedures |
147 |
|
New IBD Consult Referral |
93 |
|
Referrals to Surgery from IBD clinic |
0 |
|
Hospital Admissions of patients cared in IBD clinic |
0 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA-Erasmo in CD |
|
|
Dr. Navaneethan |
135 |
|
Dr. Agarwal |
- |
|
Ryan Anderson, PA-C |
75 |
|
Smithamol- Greegorious |
63 |
|
Dietician |
96 |
|
Mental Health Therapist |
38 |
|
Total Visits |
407 |
|
Colonoscopy |
112 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ilescopy, Flexible Sigmoidoscopy |
26 |
|
|
Total Procedures |
138 |
|
New IBD Consult Referral |
59 |
|
Referrals to Surgery from IBD clinic |
0 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
2 |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA-Erasmo in CD |
|
|
Dr. Navaneethan |
98 |
|
Dr. Agarwal |
104 |
|
Ryan Anderson, PA-C |
77 |
|
Smithamol- Greegorious |
57 |
|
Dietician |
68 |
|
Mental Health Therapist |
42 |
|
Total Visits |
356 |
|
Colonoscopy |
80 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ilescopy, Flexible Sigmoidoscopy |
19 |
|
|
Total Procedures |
99 |
|
New IBD Consult Referral |
93 |
|
Referrals to Surgery from IBD clinic |
0 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA-Erasmo in CD |
|
|
Dr. Navaneethan |
153 |
|
Dr. Agarwal |
162 |
|
Ryan Anderson, PA-C |
72 |
|
Smithamol- Greegorious |
46 |
|
Dietician |
59 |
|
Mental Health Therapist |
48 |
|
Total Visits |
540 |
|
Colonoscopy |
88 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ilescopy, Flexible Sigmoidoscopy |
28 |
|
|
Total Procedures |
116 |
|
New IBD Consult Referral |
40 |
|
Referrals to Surgery from IBD clinic |
0 |
|
Hospital Admissions of patients cared in IBD clinic |
0 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA-Erasmo in CD |
|
|
Dr. Navaneethan |
131 |
|
Dr. Agarwal |
114 |
|
APPs (R. Anderson and S. Thomas) |
61 |
|
Dietician |
60 |
|
Mental Health Therapist |
44 |
|
Total Visits |
409 |
|
Colonoscopy |
90 |
|
|
Pouchoscopy, EGD, Enteroscopy, EUS, Ilescopy, Flexible Sigmoidoscopy |
18 |
|
|
Total Procedures |
108 |
|
New IBD Consult Referral |
47 |
|
Referrals to Surgery from IBD clinic |
1 |
|
Hospital Admissions of patients cared in IBD clinic |
0 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA-Erasmo in CD |
|
|
Dr. Navaneethan |
131 |
|
Dr. Agarwal |
114 |
|
Ryan Anderson, PA-C |
27 |
|
Smithamol Greegorious Thomas, APRN |
34 |
|
Dietitian |
60 |
|
Mental Health Therapist |
44 |
|
Total Visits |
409 |
|
Colonoscopy |
90 |
|
|
Pouchoscopy |
2 |
|
|
EGD |
7 |
|
|
Enteroscopy |
5 |
|
|
EUS |
|
2 |
|
Ileoscopy |
|
1 |
|
Flexible Sigmoidoscopy |
|
1 |
|
Total Procedures |
108 |
|
New IBD Consult Referral |
33 |
|
Referrals to Surgery from IBD clinic |
1 |
|
Hospital Admissions of patients cared in IBD clinic |
|
|
ER Visits of patients cared in IBD clinic |
|
|
AGA/CCFA Quality measures-compliance |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
RENA-Erasmo in CD |
|
|
Dr. Navaneethan |
176 |
|
Dr. Agarwal |
135 |
|
Ryan Anderson, PA-C |
19 |
|
Smithamol Greegorious Thomas, APRN |
22 |
|
Dietitian |
46 |
|
Mental Health Therapist |
41 |
|
Total Visits |
439 |
|
Patient initiated/maintained on biologics/small molecules |
|
Colonoscopy |
103 |
|
|
Pouchoscopy |
5 |
|
|
EGD |
17 |
|
|
Enteroscopy |
1 |
|
|
EUS |
|
3 |
|
Ileoscopy |
|
2 |
|
Flexible Sigmoidoscopy |
|
2 |
|
Total Procedures |
133 |
|
New IBD Consult Referral |
37 |
|
Referrals to Surgery from IBD clinic |
3 |
|
Hospital Admissions of patients cared in IBD clinic |
6 |
|
ER Visits of patients cared in IBD clinic |
3 |
|
AGA/CCFA Quality measures-compliance |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
173 |
|
Dr. Agarwal |
90 |
|
Ryan Anderson, PA-C |
19 |
|
Smithamol Greegorious Thomas, APRN |
26 |
|
Dietitian |
54 |
|
Mental Health Therapist |
46 |
|
Total Visits |
408 |
|
Patient initiated/maintained on biologics/small molecules |
|
Colonoscopy |
63 |
|
|
Pouchoscopy |
4 |
|
|
EGD |
13 |
|
|
Enteroscopy |
6 |
|
|
EUS |
|
7 |
|
Ileoscopy |
|
2 |
|
Flexible Sigmoidoscopy |
|
3 |
|
Total Procedures |
98 |
|
New IBD Consult Referral |
45 |
|
Referrals to Surgery from IBD clinic |
2 |
|
Hospital Admissions of patients cared in IBD clinic |
4 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
AGA/CCFA Quality measures-compliance |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
187 |
|
Dr. Agarwal |
101 |
|
Ryan Anderson, PA-C |
24 |
|
Dietitian |
60 |
|
Mental Health Therapist |
41 |
|
Total Visits |
413 |
|
Patient initiated/maintained on biologics/small molecules |
|
Colonoscopy |
80 |
|
|
Pouchoscopy |
5 |
|
|
EGD |
5 |
|
|
Enteroscopy |
1 |
|
|
EUS |
|
1 |
|
Ileoscopy |
|
3 |
|
Flexible Sigmoidoscopy |
|
2 |
|
Total Procedures |
97 |
|
New IBD Consult Referral |
46 |
|
Referrals to Surgery from IBD clinic |
1 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
2 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
175 |
|
Dr. Agarwal |
155 |
|
Ryan Anderson, PA-C |
28 |
|
Dietitian |
78 |
|
Mental Health Therapist |
34 |
|
Total Visits |
470 |
|
Patient initiated/maintained on biologics/small molecules |
|
Colonoscopy |
64 |
|
|
Pouchoscopy |
2 |
|
|
EGD |
15 |
|
|
Enteroscopy |
0 |
|
|
EUS |
|
3 |
|
ERCP |
|
0 |
|
Ileoscopy |
|
2 |
|
Flexible Sigmoidoscopy |
|
2 |
|
Total Procedures |
88 |
|
New IBD Consult Referral |
61 |
|
Referrals to Surgery from IBD clinic |
4 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
147 |
|
Dr. Agarwal |
114 |
|
Dietitian |
74 |
|
Mental Health Therapist |
49 |
|
Total Visits |
384 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
104 |
|
|
Pouchoscopy |
5 |
|
|
EGD |
19 |
|
|
Enteroscopy |
6 |
|
|
EUS |
|
14 |
|
ERCP |
|
1 |
|
Ileoscopy |
|
1 |
|
Flexible Sigmoidoscopy |
|
1 |
|
Total Procedures |
151 |
|
New IBD Consult Referral |
41 |
|
Referrals to Surgery from IBD clinic |
4 |
|
Hospital Admissions of patients cared in IBD clinic |
4 |
|
ER Visits of patients cared in IBD clinic |
2 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
157 |
|
Dr. Agarwal |
47 |
|
Dietitian |
89 |
|
Mental Health Therapist |
58 |
|
Total Visits |
353 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
74 |
|
|
Pouchoscopy |
4 |
|
|
EGD |
12 |
|
|
Enteroscopy |
4 |
|
|
EUS |
|
7 |
|
ERCP |
|
0 |
|
Ileoscopy |
|
0 |
|
Flexible Sigmoidoscopy |
|
3 |
|
Total Procedures |
104 |
|
New IBD Consult Referral |
56 |
|
Referrals to Surgery from IBD clinic |
3 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
4 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
204 |
|
Dr. Agarwal |
168 |
|
Dietitian |
80 |
|
Mental Health Therapist |
44 |
|
Total Visits |
496 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
122 |
|
|
Pouchoscopy |
5 |
|
|
EGD |
19 |
|
|
Enteroscopy |
6 |
|
|
EUS |
|
13 |
|
ERCP |
|
0 |
|
Ileoscopy |
|
2 |
|
Flexible Sigmoidoscopy |
|
2 |
|
Total Procedures |
167 |
|
New IBD Consult Referral |
74 |
|
Referrals to Surgery from IBD clinic |
4 |
|
Hospital Admissions of patients cared in IBD clinic |
7 |
|
ER Visits of patients cared in IBD clinic |
2 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
155 |
|
Dr. Agarwal |
136 |
|
Jenny - Dietitian |
58 |
|
Dipti - Mental Health Therapist |
35 |
|
Total Visits |
384 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
74 |
|
|
Pouchoscopy |
1 |
|
|
EGD |
19 |
|
|
Enteroscopy |
4 |
|
|
EUS |
|
1 |
|
ERCP |
|
0 |
|
Ileoscopy |
|
2 |
|
Flexible Sigmoidoscopy |
|
4 |
|
Total Procedures |
105 |
|
New IBD Consult Referral |
64 |
|
Referrals to Surgery from IBD clinic |
0 |
|
Hospital Admissions of patients cared in IBD clinic |
2 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
168 |
|
Dr. Agarwal |
164 |
|
Jenny - Dietitian |
79 |
|
Dipti - Mental Health Therapist |
32 |
|
Total Visits |
443 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
92 |
|
|
Pouchoscopy |
3 |
|
|
EGD |
28 |
|
|
Double balloon enteroscopy |
5 |
|
|
EUS |
|
8 |
|
Flexible Sigmoidoscopy |
|
4 |
|
Total Procedures |
140 |
|
New IBD Consult Referral |
65 |
|
Referrals to Surgery from IBD clinic |
3 |
|
Hospital Admissions of patients cared in IBD clinic |
5 |
|
ER Visits of patients cared in IBD clinic |
6 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
2 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study in recurrent CDI |
3 |
|
NEXUS Study in UC |
2 |
|
VTX Study in CD |
1 |
| PALATIN IN UC |
1 |
|
Dr. Navaneethan |
199 |
|
Dr. Agarwal |
144 |
|
Jenny - Dietitian |
68 |
|
Dipti - Mental Health Therapist |
34 |
|
Total Visits |
445 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
115 |
|
|
Pouchoscopy |
6 |
|
|
EGD |
41 |
|
|
Enteroscopy |
21 |
|
|
EUS |
|
16 |
|
ERCP |
|
1 |
|
Ileoscopy |
|
0 |
|
Flexible Sigmoidoscopy |
|
4 |
|
Total Procedures |
204 |
|
New IBD Consult Referral |
11 |
|
Referrals to Surgery from IBD clinic |
1 |
|
Hospital Admissions of patients cared in IBD clinic |
2 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
79 |
|
Dr. Agarwal |
81 |
|
Jenny - Dietitian |
51 |
|
Dipti - Mental Health Therapist |
33 |
|
Total Visits |
244 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
104 |
|
|
Pouchoscopy |
1 |
|
|
EGD |
18 |
|
|
Enteroscopy |
6 |
|
|
EUS |
|
3 |
|
ERCP |
|
1 |
|
Ileoscopy |
|
0 |
|
Flexible Sigmoidoscopy |
|
4 |
|
Total Procedures |
137 |
|
New IBD Consult Referral |
10 |
|
Referrals to Surgery from IBD clinic |
4 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
158 |
|
Dr. Agarwal |
128 |
|
Jenny - Dietitian |
65 |
|
Dipti - Mental Health Therapist |
31 |
|
Total Visits |
382 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
78 |
|
|
Pouchoscopy |
4 |
|
|
EGD |
23 |
|
|
Enteroscopy |
6 |
|
|
EUS |
|
9 |
|
ERCP |
|
0 |
|
Ileoscopy |
|
1 |
|
Flexible Sigmoidoscopy |
|
2 |
|
Total Procedures |
123 |
|
New IBD Consult Referral |
17 |
|
Referrals to Surgery from IBD clinic |
10 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
3 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
157 |
|
Dr. Agarwal |
100 |
|
Jenny - Dietitian |
84 |
|
Dipti - Mental Health Therapist |
49 |
|
Total Visits |
390 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Colonoscopy |
130 |
|
|
Pouchoscopy |
4 |
|
|
EGD |
61 |
|
|
Enteroscopy |
13 |
|
|
EUS |
|
20 |
|
ERCP |
|
1 |
|
Ileoscopy |
|
2 |
|
Flexible Sigmoidoscopy |
|
3 |
|
Total Procedures |
234 |
|
New IBD Consult Referral |
17 |
|
Referrals to Surgery from IBD clinic |
8 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
3 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
|
|
AMAM-Mirikizumab in CD |
|
|
Rebiotix Study |
|
|
ARENA-Erasmo in CD |
|
|
Dr. Navaneethan |
155 |
|
Dr. Agarwal |
55 |
|
Jenny - Dietitian |
46 |
|
Dipti - Mental Health Therapist |
45 |
|
Total Visits |
301 |
|
Patient initiated/maintained on biologics/small molecules |
99% |
|
Procedures-IBD related by |
Navaneethan |
Agarwal |
|
Colonoscopy |
79 |
|
|
Pouchoscopy |
4 |
|
|
EGD |
30 |
|
|
Enteroscopy |
17 |
|
|
EUS |
9 |
|
|
ERCP |
2 |
|
|
Ileoscopy |
1 |
|
|
Flexible Sigmoidoscopy |
3 |
|
|
Total Procedures |
145 |
|
|
New IBD Consult Referrals for Dr. Navaneethan |
18 |
|
New IBD Consult Referrals for Dr. Agarwal |
0 |
|
Referrals to Surgery from IBD clinic |
4 |
|
Hospital Admissions of patients cared in IBD clinic |
5 |
|
ER Visits of patients cared in IBD clinic |
5 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
171 |
|
Dr. Agarwal |
107 |
|
Total Visits |
1278 |
|
Patient initiated/maintained on biologics/small molecules |
98% |
|
Procedures-IBD related by |
Navaneethan |
Agarwal |
|
Colonoscopy |
93 |
|
|
Pouchoscopy |
2 |
|
|
EGD |
32 |
|
|
Enteroscopy |
7 |
|
|
EUS |
21 |
|
|
ERCP |
3 |
|
|
Ileoscopy |
2 |
|
|
Flexible Sigmoidoscopy |
3 |
|
|
Total Procedures |
163 |
|
|
New IBD Consult Referrals for Dr. Navaneethan |
24 |
|
New IBD Consult Referrals for Dr. Agarwal |
|
|
Referrals to Surgery from IBD clinic |
5 |
|
Hospital Admissions of patients cared in IBD clinic |
0 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
115 |
|
Dr. Agarwal |
74 |
|
Total Visits |
189 |
|
Patient initiated/maintained on biologics/small molecules |
98% |
|
Procedures-IBD related by |
Navaneethan |
Agarwal |
|
Colonoscopy |
63 |
|
|
Pouchoscopy |
2 |
|
|
EGD |
31 |
|
|
Enteroscopy |
9 |
|
|
EUS |
6 |
|
|
ERCP |
0 |
|
|
Ileoscopy |
0 |
|
|
Flexible Sigmoidoscopy |
6 |
|
|
Total Procedures |
117 |
|
|
New IBD Consult Referrals for Dr. Navaneethan |
24 |
|
New IBD Consult Referrals for Dr. Agarwal |
|
|
Referrals to Surgery from IBD clinic |
1 |
|
Hospital Admissions of patients cared in IBD clinic |
4 |
|
ER Visits of patients cared in IBD clinic |
4 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
169 |
|
Dr. Agarwal |
62 |
|
Total Visits |
231 |
|
Patient initiated/maintained on biologics/small molecules |
98% |
|
Procedures-IBD related by |
Navaneethan |
Agarwal |
|
Colonoscopy |
80 |
14 |
|
Pouchoscopy |
4 |
0 |
|
EGD |
19 |
6 |
|
Enteroscopy |
12 |
0 |
|
EUS |
7 |
0 |
|
ERCP |
0 |
0 |
|
Ileoscopy |
0 |
0 |
|
Flexible Sigmoidoscopy |
10 |
0 |
|
Total Procedures |
132 |
20 |
|
New IBD Consult Referrals for Dr. Navaneethan |
23 |
|
New IBD Consult Referrals for Dr. Agarwal |
8 |
|
Referrals to Surgery from IBD clinic |
5 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
2 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
153 |
|
Dr. Agarwal |
77 |
|
Total Visits |
230 |
|
Patient initiated/maintained on biologics/small molecules |
98% |
|
Procedures-IBD related by |
Navaneethan |
Agarwal |
|
Colonoscopy |
75 |
16 |
|
Pouchoscopy |
0 |
0 |
|
EGD |
12 |
8 |
|
Enteroscopy |
15 |
0 |
|
EUS |
8 |
0 |
|
ERCP |
1 |
0 |
|
Ileoscopy |
1 |
0 |
|
Flexible Sigmoidoscopy |
5 |
1 |
|
Total Procedures |
117 |
25 |
|
New IBD Consult Referrals for Dr. Navaneethan |
16 |
|
New IBD Consult Referrals for Dr. Agarwal |
6 |
|
Referrals to Surgery from IBD clinic |
1 |
|
Hospital Admissions of patients cared in IBD clinic |
0 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
151 |
|
Dr. Agarwal |
66 |
|
Total Visits |
217 |
|
Patient initiated/maintained on biologics/small molecules |
98% |
|
Procedures-IBD related by |
Navaneethan |
Agarwal |
|
Colonoscopy |
69 |
9 |
|
Pouchoscopy |
3 |
1 |
|
EGD |
29 |
7 |
|
Enteroscopy |
17 |
0 |
|
EUS |
15 |
0 |
|
ERCP |
1 |
0 |
|
Ileoscopy |
2 |
0 |
|
Flexible Sigmoidoscopy |
1 |
0 |
|
Total Procedures |
137 |
17 |
|
New IBD Consult Referrals for Dr. Navaneethan |
31 |
|
New IBD Consult Referrals for Dr. Agarwal |
4 |
|
Referrals to Surgery from IBD clinic |
10 |
|
Hospital Admissions of patients cared in IBD clinic |
6 |
|
ER Visits of patients cared in IBD clinic |
6 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
152 |
|
Dr. Agarwal |
56 |
|
Total Visits |
208 |
|
Patient initiated/maintained on biologics/small molecules |
98% |
|
Colonoscopy |
71 |
|
Pouchoscopy |
1 |
|
EGD |
25 |
|
Enteroscopy |
16 |
|
EUS |
20 |
|
ERCP |
4 |
|
Ileoscopy |
1 |
|
Flexible Sigmoidoscopy |
1 |
|
Total Procedures |
139 |
|
New IBD Consult Referrals |
36 |
|
Referrals to Surgery from IBD clinic |
2 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
1 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
1 |
|
AMAM-Mirikizumab in CD |
2 |
|
Rebiotix Study |
3 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
126 |
|
Physician Assistants (1.1 FTE) |
78 |
|
Kalee Eichelberger Dietitian |
53 |
|
Total number of patient visits |
257 |
|
Patient initiated/maintained on biologics/small molecules |
97% |
|
Colonoscopy |
61 |
|
Pouchoscopy |
2 |
|
EGD |
19 |
|
Enteroscopy |
14 |
|
EUS |
10 |
|
Ileoscopy |
2 |
|
Flexible Sigmoidoscopy |
2 |
|
Total Procedures |
115 |
|
New IBD Consult Referrals-New |
36 |
|
Referrals to Surgery from IBD clinic |
4 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
3 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
1 |
|
AMAM-Mirikizumab in CD |
1 |
|
Rebiotix Study |
3 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
126 |
|
Physician Assistants (1.1 FTE) |
83 |
|
Kalee Eichelberger Dietitian |
68 |
|
Total number of patient visits |
277 |
|
Patient initiated/maintained on biologics/small molecules |
97% |
|
Colonoscopy |
57 |
|
Pouchoscopy |
4 |
|
EGD |
14 |
|
Enteroscopy |
20 |
|
EUS |
16 |
|
ERCP |
13 |
|
Ileoscopy |
1 |
|
Total Procedures |
125 |
|
New IBD Consult Referrals-New |
29 |
|
Referrals to Surgery from IBD clinic |
2 |
|
Hospital Admissions of patients cared in IBD clinic |
1 |
|
ER Visits of patients cared in IBD clinic |
5 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
64 |
|
Physician Assistants (1.1 FTE) |
60 |
|
Kalee Eichelberger Dietitian |
29 |
|
Total number of patient visits |
153 |
|
Patient initiated/maintained on biologics/small molecules |
97% |
|
Colonoscopy |
46 |
|
Pouchoscopy |
3 |
|
EGD |
11 |
|
Enteroscopy |
7 |
|
EUS |
5 |
|
ERCP |
4 |
|
Total Procedures |
76 |
|
New IBD Consult Referrals-New |
35 |
|
Referrals to Surgery from IBD clinic |
2 |
|
Hospital Admissions of patients cared in IBD clinic |
0 |
|
ER Visits of patients cared in IBD clinic |
0 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
82 |
|
Physician Assistants (1.1 FTE) |
64 |
|
Kalee Eichelberger Dietitian |
38 |
|
Total number of patient visits |
184 |
|
Patient initiated/maintained on biologics/small molecules |
95% |
|
Total procedures by Dr.Navaneethan |
134 |
|
Colonoscopy |
81 |
|
EGD |
23 |
|
Enteroscopy |
8 |
|
EUS |
6 |
|
Total Procedures |
118 |
|
New IBD Consult Referrals-New |
46 |
|
Referrals to Surgery from IBD clinic |
7 |
|
Hospital Admissions of patients cared in IBD clinic |
5 |
|
ER Visits of patients cared in IBD clinic |
5 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
1 |
|
AMAM-Mirikizumab in CD |
1 |
|
Rebiotix Study |
3 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
120 |
|
Physician Assistants (1.1 FTE) |
72 |
|
Kalee Eichelberger Dietitian |
49 |
|
Total number of patient visits |
241 |
|
Patient initiated/maintained on biologics/small molecules |
95% |
|
Colonoscopy |
86 |
|
Pouchoscopy |
4 |
|
EGD |
27 |
|
Enteroscopy |
11 |
|
EUS |
9 |
|
ERCP |
2 |
|
Total Procedures |
139 |
|
New IBD Consult Referrals-New |
31 |
|
Referrals to Surgery from IBD clinic |
0 |
|
Hospital Admissions of patients cared in IBD clinic |
3 |
|
ER Visits of patients cared in IBD clinic |
7 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
112 |
|
Physician Assistants (1.1 FTE) |
53 |
|
Kalee Eichelberger Dietitian |
42 |
|
Total number of patient visits |
207 |
|
Patient initiated/maintained on biologics/small molecules |
95% |
|
Colonoscopy |
56 |
|
Pouchoscopy |
2 |
|
EGD |
19 |
|
Enteroscopy |
9 |
|
EUS |
14 |
|
ERCP |
4 |
|
Flexible Sigmoidoscopy |
1 |
|
Total Procedures |
105 |
|
New IBD Consult Referrals-New |
25 |
|
Referrals to Surgery from IBD clinic |
2 |
|
Hospital Admissions of patients cared in IBD clinic |
2 |
|
ER Visits of patients cared in IBD clinic |
4 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
0 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
0 |
|
ARENA-Erasmo in CD |
0 |
|
Dr. Navaneethan |
152 |
|
Physician Assistants (0.1 FTE) |
11 |
|
Kalee Eichelberger Dietitian |
47 |
|
Total number of patient visits |
210 |
|
Patient initiated/maintained on biologics/small molecules |
95% |
|
Colonoscopy |
88 |
|
Pouchoscopy |
3 |
|
EGD |
23 |
|
Enteroscopy |
8 |
|
EUS |
7 |
|
ERCP |
1 |
|
Flexible Sigmoidoscopy |
4 |
|
Total Procedures |
134 |
|
New IBD Consult Referrals-New |
49 |
|
Referrals to Surgery from IBD clinic |
6 |
|
Hospital Admissions of patients cared in IBD clinic |
4 |
|
ER Visits of patients cared in IBD clinic |
4 |
|
AGA/CCFA Quality measures-compliance |
100% |
|
QUASAR trial-Guselkumab in UC |
1 |
|
AMAM-Mirikizumab in CD |
0 |
|
Rebiotix Study |
3 |
|
ARENA-Etrasimod in CD |
0 |
| Dr. Navaneethan | 100 |
| Physician Assistant-Vanessa (0.7 FTE) | 52 |
| Kalee Eichelberger Dietitian | 27 |
| Total number of patient visits | 179 |
| Patient initiated/maintained on biologics/small molecules | 90% |
| Total number of procedures by Dr. Navaneethan | 106 |
| Colonoscopy | 60 |
| Pouchoscopy with stricturotomy | 2 |
| Upper Endoscopy | 19 |
| Double balloon enteroscopy | 1 |
| EUS | 2 |
| Flexible Sigmoidoscopy with fistula closure | 1 |
| Total Procedures | 85 |
| New IBD Consult Referrals | 36 |
| Referrals to Surgery from IBD clinic | 3 |
| Hospital Admissions of patients cared in IBD clinic | 3 |
| ER Visits of patients cared in IBD clinic-both got admitted | 5 |
| AGA/CCFA Quality measures-compliance | 100% |
| QUASAR trial-Guselkumab in UC | 1 |
| AMAM-Mirikizumab in CD | 0 |
| Rebiotix Study-CDI in IBD | 3 |
| ARENA-Etrasimod in CD | 0 |
| Dr. Navaneethan | 103 |
| Physician Assistant-Vanessa (0.7 FTE) | 89 |
| Kalee Eichelberger Dietitian | 47 |
| Total number of patient visits | 239 |
| Patient initiated/maintained on biologics/small molecules | 86% |
| Total number of procedures by Dr. Navaneethan | 114 |
| Colonoscopy | 55 |
| Pouchoscopy | 3 |
| EGD | 10 |
| Double balloon enteroscopy | 1 |
| EUS | 1 |
| Flexible Sigmoidoscopy | 2 |
| Total Procedures | 72 |
| New IBD Consult Referrals | 55 |
| Referrals to Surgery from IBD clinic | 5 |
| Hospital Admissions of patients cared in IBD clinic | 3 |
| ER Visits of patients cared in IBD clinic-both got admitted | 6 |
| AGA/CCFA Quality measures-compliance | 100% |
| QUASAR trial-Guselkumab in UC | 1 |
| AMAM-Mirikizumab in CD | 0 |
| Rebiotix Study-Microbiome for recurrent CDI in IBD | 1 |
| ARENA-Etrasimod in CD | 0 |
| Dr. Navaneethan | 116 |
| Physician Assistants (1 FTE) | 90 |
| Kalee Eichelberger Dietitian | 52 |
| Total number of patient visits | 258 |
| Patient initiated/maintained on biologics/small molecules | 86% |
| Colonoscopy | 56 |
| EGD | 14 |
| Double Balloon Enteroscopy | 10 |
| EUS | 12 |
| Flexible Sigmoidoscopy | 1 |
| Total Procedures | 93 |
| New IBD Consult Referrals | 49 |
| Referrals to Surgery from IBD clinic | 4 |
| Hospital Admissions of patients cared in IBD clinic | 4 |
| ER Visits of patients cared in IBD clinic-both got admitted | 7 |
| AGA/CCFA Quality measures-compliance | 100% |
| QUASAR trial-Guselkumab in UC | 1 |
| AMAM-Mirikizumab in CD | 1 |
| Rebiotix Study | 0 |
| ARENA-Etrasimod in CD | 0 |
| Dr. Navaneethan | 96 |
| Kaitlin Collela Clinic PA | 34 |
| Kalee Eichelberger Dietitian | 37 |
| Total number of patient visits | 206 |
| Patient initiated/maintained on biologics/small molecules | 75% |
| Colonoscopy | 59 |
| EGD and Colonoscopy | 8 |
| ERCP | 8 |
| EGD | 10 |
| EGD and EUS | 2 |
| Enteroscopy | 15 |
| Enteroscopic US Upper | 10 |
| Upper GI Endoscopy | 1 |
| Flexible Sigmoidoscopy | 2 |
| Enteroscopy w/Fluoro Upper | 1 |
| Pouchoscopy | 2 |
| Total Procedures | 118 |
| IBD Consult Referrals-New | 39 |
| Referrals to Surgery from IBD clinic | 6 |
| Hospital Admissions of patients cared in IBD clinic | 6 |
| ER Visits of patients cared in IBD clinic-both got admitted | 6 |
| AGA/CCFA Quality measures-compliance | 100% |
| QUASAR trial-Guselkumab in UC | |
| AMAM-Mirikizumab in CD |
| Dr. Navaneethan | 114 |
| Kaitlin Collela Clinic PA | 39 |
| Kalee Eichelberger Dietitian | 23 |
| Total number of patient visits | 207 |
| Patient initiated/maintained on biologics/small molecules | 97% |
| Colonoscopy including chromoendoscopy/EMR, stricture therapy | 58 |
| EGD | 20 |
| EGD and EUS | 10 |
| Double Balloon Enteroscopy/Small bowel enteroscopy | 3 |
| Pouchoscopy with closure of enterocutaneous fistula | 1 |
| Total Procedures | 92 |
| IBD Consult Referrals-New | 95 |
| Referrals to Surgery from IBD clinic | 4 |
| Hospital Admissions of patients cared in IBD clinic | 2 |
| ER Visits of patients cared in IBD clinic-both got admitted | 2 |
| AGA/CCFA Quality measures-compliance | 100% |
| QUASAR trial-Guselkumab in UC | 1 |
| AMAM-Mirikizumab in CD | 1-Screening |
| Dr. Navaneethan Clinic Visits | 100 |
| Kaitlin Collela, PA, Clinic Visits | 45 |
| Kalee Eichelberger, RD, LDN, Clinic Visits | 15 |
| New IBD Consult Referrals | 80 |
| Referral to Surgery from IBD clinic | 4 |
| Patient initiated/maintained on Biologics/small molecules | 98% |
| Colonoscopy including chromoendoscopy/EMR, stricture therapy | 46 |
| EGD/Colonoscopy | 4 |
| Double balloon Enteroscopy | 5 |
| Flexible Sigmoidoscopy | 1 |
| Total Procedures | 56 |
| IBD related Hospital Admissions of patients cared in IBD clinic | 0 |
| IBD related ER Visits of patients cared in IBD clinic | 0 |
| AGA/CCFA Quality measures-compliance | 100% |
| QUASAR trial-Guselkumab in UC | 1 |
| AMAM-Mirikizumab in CD | 0 |
| Dr. Navaneethan Clinic Visits | 77 |
| Kaitlin Collela, PA, Clinic Visits | 8 |
| Kalee Eichelberger, RD, LDN, Clinic Visits | 13 |
| % Patient on Biologics | 99% |
| Colonoscopy | 36 |
| EUS | 9 |
| EGD | 6 |
| ERCP | 5 |
| EUS/ERCP | 5 |
| EGD/Colonoscopy | 2 |
| EGD/EUS | 2 |
| Enterscopy | 1 |
| Total Procedures | 66 |
| Clinic Referrals | 90 |
| Referral to Surgery | |
| Hospital Admissions | 10 |
| ER Visits |
